Magovcevic-Liebisch Ivana — SEC insider filings

SEC reporting owner CIK 1279281. 24 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2020-12-18 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Vigil Neuroscience, Inc. (VIGL)President and CEO, Director116 legs · 24,000 sh · $61,829—17
Quanterix Corp (QTRX)Director3——5
Acrivon Therapeutics, Inc. (ACRV)Director4——4
Aeglea BioTherapeutics, Inc. (AGLE)Director3——3
APPLIED GENETIC TECHNOLOGIES CORP (AGTC)Director2——2
Absci Corp (ABSI)Director1——1

Insider filings — Magovcevic-Liebisch Ivana

FiledFormIssuerReported transactionsSource
2026-10-024Quanterix Corp (QTRX)Option exercise (M): 4,224 · Option exercise (M): 4,224 (derivative) @ $0EDGAR
2026-06-224Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 20,275 (derivative) @ $0EDGAR
2026-05-204Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 9,366 @ $0EDGAR
2026-01-154Quanterix Corp (QTRX)Grant/award (A): 23,372 @ $0EDGAR
2025-08-054Vigil Neuroscience, Inc. (VIGL)Disposition to issuer (D): 222,687 · Disposition to issuer (D): 369,351 (derivative) · Disposition to issuer (D): 210,629 (derivative) · Disposition to issuer (D): 405,494 (derivative) · Disposition to issuer (D): 43,271 (derivative) · Disposition to issuer (D): 282,000 (derivative) · +3 moreEDGAR
2025-06-174Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 20,275 (derivative) @ $0EDGAR
2025-03-044Vigil Neuroscience, Inc. (VIGL)Grant/award (A): 485,000 (derivative) @ $0EDGAR
2024-12-194Vigil Neuroscience, Inc. (VIGL)Purchase (P): 5,000 @ $1.68EDGAR
2024-12-184Vigil Neuroscience, Inc. (VIGL)Purchase (P): 5,000 @ $1.67EDGAR
2024-12-054Vigil Neuroscience, Inc. (VIGL)Purchase (P): 5,000 @ $2.34EDGAR
2024-10-034Quanterix Corp (QTRX)Grant/award (A): 12,800 @ $0 · Grant/award (A): 27,689 (derivative) @ $0EDGAR
2024-05-074Vigil Neuroscience, Inc. (VIGL)Disposition to issuer (D): 282,000 (derivative) @ $0 · Grant/award (A): 282,000 (derivative) @ $0 · Disposition to issuer (D): 370,000 (derivative) @ $0 · Grant/award (A): 370,000 (derivative) @ $0EDGAR
2024-03-014Vigil Neuroscience, Inc. (VIGL)Grant/award (A): 463,000 (derivative) @ $0EDGAR
2024-02-094Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 32,500 (derivative) @ $0EDGAR
2023-11-204Vigil Neuroscience, Inc. (VIGL)Purchase (P): 4,000 @ $3.75EDGAR
2023-06-304Aeglea BioTherapeutics, Inc. (AGLE)Grant/award (A): 1,950,000 (derivative) @ $0EDGAR
2023-03-034Vigil Neuroscience, Inc. (VIGL)Grant/award (A): 370,000 (derivative) @ $0EDGAR
2022-06-104Absci Corp (ABSI)Grant/award (A): 28,700 (derivative) @ $0EDGAR
2022-06-094Aeglea BioTherapeutics, Inc. (AGLE)Grant/award (A): 43,000 (derivative) @ $0EDGAR
2022-05-044Vigil Neuroscience, Inc. (VIGL)Purchase (P): 4,000 @ $3.61 · Purchase (P): 1,000 @ $3.94EDGAR
2022-03-034Vigil Neuroscience, Inc. (VIGL)Grant/award (A): 282,000 (derivative) @ $0EDGAR
2021-12-024APPLIED GENETIC TECHNOLOGIES CORP (AGTC)Grant/award (A): 14,000 (derivative) @ $0EDGAR
2021-06-094Aeglea BioTherapeutics, Inc. (AGLE)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2020-12-184APPLIED GENETIC TECHNOLOGIES CORP (AGTC)Grant/award (A): 12,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1279281 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs